The Mesothelioma Center News – Page 22
-
news
Legislation & LitigationSecondary exposure to toxic asbestos has declined considerably in recent decades, but known cases of malignant mesothelioma caused by that type of… -
news
Legislation & LitigationEPA Settles Lawsuits, Agrees to Broader Asbestos Risk Evaluations
Facing legal pressure from health and advocacy organizations, the U.S. Environmental Protection Agency has agreed to broaden its ongoing Risk Evaluation for Asbestos under… -
news
Research & Clinical TrialsResearchers Open Phase I Clinical Trial of Cryoablation with Keytruda
Memorial Sloan Kettering Cancer Center in New York City has opened a novel clinical trial that combines the immunotherapy drug Keytruda with… -
news
Research & Clinical TrialsNew Opdivo/Yervoy Mesothelioma Clinical Trial Begins Soon
A novel clinical trial involving the immunotherapy combination of Opdivo and Yervoy will open soon in Chicago. The goal is to study the… -
news
Treatment & DoctorsVirtual Symposium to Focus on Mesothelioma Treatment Advances
Sylvester Comprehensive Cancer Center of South Florida will host its free virtual First Miami International Mesothelioma Symposium on November 6, 2021. The Mesothelioma Program… -
news
Asbestos Exposure & BansAsbestos Cleanup Moving Forward at EPA’s Libby Superfund Site
Decontamination efforts in Libby, Montana – the largest asbestos cleanup project in American history – moved another step closer to completion this month,… -
news
Research & Clinical TrialsStudy Shows Access to Care Often Difficult for Mesothelioma Patients
When it comes to malignant pleural mesothelioma, not everyone is treated equally. A disparity in access to care makes the difference in… -
news
Asbestos Exposure & Bans2021 ADAO Asbestos Awareness Conference Runs Sept. 17-18
The 16th Annual International Asbestos Awareness and Prevention Conference takes place Sept. 17-18, featuring 40 speakers from seven countries plus the first-ever Art, Advocacy… -
news
Research & Clinical TrialsMesothelioma Research, COVID Findings Featured at IASLC Conference
Researchers from around the world presented their insights into serious lung health issues, including mesothelioma, during the International Association for the Study of… -
news
Research & Clinical TrialsRamucirumab Shows Survival Benefits with Pleural Mesothelioma
Adding the drug ramucirumab to gemcitabine chemotherapy worked especially well in a recent clinical trial involving second-line treatment for patients with…